http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24903732

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 9
issn 1557-2501
issueIdentifier 3
pageRange 84-9
publicationName The Journal of invasive cardiology
startingPage 84
bibliographicCitation Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW; On-TIME 2 Trial Investigators. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score. J Invasive Cardiol. 2012 Mar;24(3):84–9. PMID: 22388296.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcb333a90627e65ee2aec4cae59e2593
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3add01a8a76a121c9050e9371d61af41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2d8bee798b427b98ee5941c374d113d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac30b7da6218c23b24e3246d3ec9ccd2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9042dbcddec3db391b742b27e5d50af1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34fbcb7299f1e9f3ba1074cbe72a0e88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc77a3fcc86e30fce0d7928a68d7a89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b5589d3666727b7ba41f60982e3ab68
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3c12e5ab0215c187712a5506da97e3b
date 201203
identifier https://pubmed.ncbi.nlm.nih.gov/22388296
isPartOf https://portal.issn.org/resource/ISSN/1557-2501
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2033
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score
discusses http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0022203
http://id.nlm.nih.gov/mesh/M0211213
http://id.nlm.nih.gov/mesh/M0010187
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0028424
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0155432
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004632
http://id.nlm.nih.gov/mesh/D004562
http://id.nlm.nih.gov/mesh/D019039Q000037
http://id.nlm.nih.gov/mesh/D014443Q000031
http://id.nlm.nih.gov/mesh/D015906
http://id.nlm.nih.gov/mesh/D006470Q000453
http://id.nlm.nih.gov/mesh/D009203Q000628
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000077466
http://id.nlm.nih.gov/mesh/D001026Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D014443Q000627
http://id.nlm.nih.gov/mesh/D006493Q000627
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D015995
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 70.